Citracal Regular 250 mg + D Interactions
There are 268 drugs known to interact with Citracal Regular 250 mg + D (calcium / vitamin d), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 17 are major, 198 are moderate, and 53 are minor.
- View all 268 medications that may interact with Citracal Regular 250 mg + D
- View Citracal Regular 250 mg + D alcohol/food interactions (1)
- View Citracal Regular 250 mg + D disease interactions (11)
Most frequently checked interactions
View interaction reports for Citracal Regular 250 mg + D (calcium / vitamin d) and the medicines listed below.
- Ambien (zolpidem)
- Aspirin Low Strength (aspirin)
- azelastine nasal
- Carafate (sucralfate)
- Celebrex (celecoxib)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Coumadin (warfarin)
- Cymbalta (duloxetine)
- Effexor XR (venlafaxine)
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- Gaviscon Regular Strength Tablets (aluminum hydroxide / magnesium trisilicate)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- hydrocodone
- ibuprofen
- Klor-Con (potassium chloride)
- lisinopril
- meloxicam
- metoprolol
- multivitamin
- omeprazole
- pravastatin
- ranitidine
- simvastatin
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Citracal Regular 250 mg + D alcohol/food interactions
There is 1 alcohol/food interaction with Citracal Regular 250 mg + D (calcium / vitamin d).
Citracal Regular 250 mg + D disease interactions
There are 11 disease interactions with Citracal Regular 250 mg + D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
More about Citracal Regular 250 mg + D (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
